Condition: ADPKD (autosomal Dominant Polycystic Kidney Disease) · Sponsor: Seoul National University Hospital
The purpose of this study is to generate clinical evidence and assess the feasibility of a shared decision-making (SDM) model for the selection of Tolvaptan in patients with ADPKD.
This description comes directly from the study's public registry record.
Jisun Chun · +82-2-2072-4072 · adpkdsdm@gmail.com
Always discuss trial participation with your own doctor first.
| Hallym University Kangnam Sacred Heart Hospital | Anyang-si, Gyeonggi-do, South Korea | Not Yet Recruiting |
| Seoul National University Hospital | Seoul, Republic of Korea, South Korea | Recruiting |
| InjeUniversityBusanPaikHospital | Busan, South Korea | Not Yet Recruiting |
| Keimyung University Dongsan Medical Center | Daegu, South Korea | Not Yet Recruiting |
| Chonnam National University Hospital | Gwangju, South Korea | Not Yet Recruiting |
| Kangbuk Samsung Hospital | Seoul, South Korea | Not Yet Recruiting |
| Asan Medical Center | Seoul, South Korea | Not Yet Recruiting |
| Seoul National University Boramae Hospital | Seoul, South Korea | Not Yet Recruiting |
| Korea University Guro Hospital | Seoul, South Korea | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06618638